Accordingly, a common candidate breast cancer-predisposition allele in HMMR, originally identified in an Ashkenazi Jewish study [23], may specifically modify breast cancer risk among BRCA1 mutation carriers. This evidence concerns the gene BRCA1 and breast cancer.